Utility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studies

BACKGROUND & AIMS: Antivirals represent the mainstay of chronic hepatitis B treatment given their efficacy and tolerability, but rates of functional cure remain low during long-term therapy. Treatment discontinuation has emerged as a strategy to maintain partial cure and achieve functional cure...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Georgia, Koffas, Apostolos, Mak, Lung-Yi, Gill, Upkar S., Kennedy, Patrick T.F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149368/
https://www.ncbi.nlm.nih.gov/pubmed/37138673
http://dx.doi.org/10.1016/j.jhepr.2023.100720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149368/
https://www.ncbi.nlm.nih.gov/pubmed/37138673
http://dx.doi.org/10.1016/j.jhepr.2023.100720

Ejemplares similares